Cargando…

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

Detalles Bibliográficos
Autores principales:	Pizzolo, G., Chilosi, M., Vinante, F., Dazzi, F., Lestani, M., Perona, G., Benedetti, F., Todeschini, G., Vincenzi, C., Trentin, L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001695/ https://www.ncbi.nlm.nih.gov/pubmed/3107607

Ejemplares similares

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission.
por: Pizzolo, G., et al.
Publicado: (1988)

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1984)

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
por: Viviani, S., et al.
Publicado: (1998)

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)

Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections.
por: Chilosi, M., et al.
Publicado: (1983)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
por: Nakata, B., et al.
Publicado: (1998)

Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
por: Fakhry, Nouran, et al.
Publicado: (2020)

The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis
por: Chen, Xiaohong, et al.
Publicado: (2020)

Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma
por: Suzuki, Kayo, et al.
Publicado: (2022)

Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL
por: MITOBE, Yuta, et al.
Publicado: (2023)

Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus
por: Almutairi, Nora, et al.
Publicado: (2020)

Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab
por: Vilaiyuk, Soamarat, et al.
Publicado: (2019)

Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency
por: van Stigt, Astrid C., et al.
Publicado: (2021)

Soluble interleukin-2 receptors in ulcerative colitis
por: Nielsen, O. H., et al.
Publicado: (1993)

Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever
por: Kanda, Naoki, et al.
Publicado: (2023)

Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma
por: Oelmann, Elisabeth, et al.
Publicado: (2015)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
por: Warzocha, K., et al.
Publicado: (1998)

Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Yue, et al.
Publicado: (2021)

Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis
por: Eurelings, Laura E. M., et al.
Publicado: (2019)

Nosocomial candidemia in an Italian tertiary care hospital
por: Luzzati, R, et al.
Publicado: (1999)

Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting
por: Bharwani, K. D., et al.
Publicado: (2020)

Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study
por: Kohsari, Maryam, et al.
Publicado: (2020)

Positive effect of ozonotherapy on serum concentration of soluble interleukin-2 receptor and neopterin in patients with systemic sclerosis
por: Nowicka, Danuta
Publicado: (2019)

Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis
por: Kobayashi, Yuta, et al.
Publicado: (2021)

Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype
por: He, Yi, et al.
Publicado: (2022)

Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study
por: Mavropoulou, Eirini, et al.
Publicado: (2020)

Serum ferritin concentration in untreated Hodgkin's disease.
por: Jacobs, A., et al.
Publicado: (1976)

The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma
por: Wodok-Wieczorek, Karolina, et al.
Publicado: (2018)

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
por: Stone, Katie, et al.
Publicado: (2013)

Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease
por: Karim, A. F., et al.
Publicado: (2018)

Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome?
por: Mangnus, Thomas J P, et al.
Publicado: (2023)

Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis
por: Miyata, Jun, et al.
Publicado: (2020)

Serum soluble interleukin-2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions
por: Murakami, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6evsns6v74q69pj2ldsis6qcgl